Farto Seguín Rosa M, Bermúdez María Bobo, Rivera Leticia, Nieto Teresa P
a Universidad de Vigo , Vigo 36310 , Spain.
J Aquat Anim Health. 2014 Dec;26(4):251-62. doi: 10.1080/08997659.2014.920734.
Preventing vibriosis in juvenile cultured Turbot Scophthalmus maximus caused by Vibrio anguillarum frequently requires the use of feed supplemented with antibiotics in addition to vaccines. Whether the use of probiotics instead of antibiotics in juvenile Turbot is a safer strategy requires more study. The antibacterial potential of 148 Vibrio spp. strains (mostly isolated from cultures of healthy oysters, clams, and Turbot) was analyzed in vitro against V. anguillarum and other pathogens by means of an agar diffusion assay. A wide spectrum of inhibitory activity was shown by 9 strains. Based on their easy phenotypic differentiation from V. anguillarum, we selected two strains (S1 and S2, both isolated from the European flat oyster Ostrea edulis) for testing in juvenile Turbot (3 g). None of the strains were virulent by intraperitoneal or bath challenges, and all were susceptible to the antibiotics most frequently used in aquaculture. Three different stocks of Turbot, which were assayed separately, were significantly protected from infection with V. anguillarum. The final survival rates of fish treated in mixed challenges with S1 or S2 and V. anguillarum were 44% and 66%, respectively, whereas only 17% of the fish treated with only the pathogenic strain survived. The application of probiotic strains also increased the survival time of juvenile Turbot after infection with V. anguillarum. Both strains persisted in the epidermal mucus layer of the fish for 30 d, and they were not displaced by the pathogen. These data prove the efficacy of using bacteria well adapted to the dynamics of culture production as a way to provide juvenile Turbot immediate protection against infection by V. anguillarum. Moreover, the epidermal mucus sampling was useful for investigating the persistence of both probiotic strains when exposed to the pathogen.
预防由鳗弧菌引起的养殖幼体大菱鲆弧菌病,除疫苗外,通常还需要使用添加抗生素的饲料。在幼体大菱鲆中使用益生菌替代抗生素是否是一种更安全的策略,还需要更多的研究。通过琼脂扩散试验,对148株弧菌属菌株(大多从健康牡蛎、蛤蜊和大菱鲆养殖环境中分离得到)的体外抗菌潜力进行了分析,以检测其对鳗弧菌和其他病原体的抗菌活性。9株菌株表现出广泛的抑制活性。基于它们与鳗弧菌易于区分的表型特征,我们选择了两株菌株(S1和S2,均从欧洲平牡蛎Ostrea edulis中分离得到)用于幼体大菱鲆(3克)试验。通过腹腔注射或浸浴攻毒,这些菌株均无致病性,并且对水产养殖中最常用的抗生素敏感。分别对三种不同的大菱鲆种群进行试验,结果显示它们均受到显著保护,免受鳗弧菌感染。在与S1或S2和鳗弧菌混合攻毒试验中,处理后的鱼最终存活率分别为44%和66%,而仅用致病菌株处理的鱼存活率仅为17%。益生菌菌株的应用还延长了幼体大菱鲆感染鳗弧菌后的存活时间。两种菌株在鱼的表皮黏液层中持续存在30天,并且未被病原体取代。这些数据证明了使用适应养殖生产动态的细菌为幼体大菱鲆提供即时保护以抵御鳗弧菌感染的有效性。此外,表皮黏液采样对于研究两种益生菌菌株在暴露于病原体时的持续性很有用。